All In Biotech

Drug Trial Radar · NCT00687713

Phase 2, Double-Blind, Placebo-Controlled Trial of Bupropion for Methamphetamine Dependence

Last checked: Nov 19, 2026Latest source record: Mar 21, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 200 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

200

Actual

Start

May 2008

Primary completion

May 2011

Study completion May 2011

Sponsor

Sponsor type
NIH
First posted
Jun 2, 2008

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is to assess the efficacy of bupropion in reducing methamphetamine use in subjects with methamphetamine dependence who report using methamphetamine 29 or less days during the 30 days prior to the start of signing consent.

Conditions

  • Methamphetamine Dependence

Interventions

  • BupropionDrug

    150mg for the first 3 days of dosing. Increased to 150 mg b.i.d until taper.

  • PlaceboOther

    Placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Subjects Showing AbstinenceTime frame: Weeks 11 and 12

Locations

12 sites in 1 country. Site status is shown where the registry gives one.

  • UCLA Integrated Substance Abuse Program

    Los Angeles, California

  • South Bay Treatment Center

    San Diego, California

  • Addiction and Pharmacology Research Laboratory

    San Francisco, California

  • Friends Research Institute

    Torrance, California

  • Matrix Institute

    Woodland Hills, California

  • Pacific Addiction Research Center - U of Hawaii

    Honolulu, Hawaii

  • Iowa Luther Hospital

    Des Moines, Iowa

  • U of Kansas Medical Center

    Kansas City, Missouri

  • New York University

    New York, New York

  • Medical University of South Carolina

    Charleston, South Carolina

  • University of Texas Health Science At San Antonio

    San Antonio, Texas

  • VA Salt Lake City Health Care System

    Salt Lake City, Utah

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.